Evidence map›Paper›PMID 26939629›Full record

ArticleAJNR. American journal of neuroradiology2016

A Novel Methodology for Applying Multivoxel MR Spectroscopy to Evaluate Convection-Enhanced Drug Delivery in Diffuse Intrinsic Pontine Gliomas.

D I Guisado, R Singh, S Minkowitz, Z Zhou, S Haque, K K Peck, R J Young, A J Tsiouris, M M Souweidane, S B Thakur

Registry-linked trialAbstract readClinical Trial, Phase I
In one paragraph

Article in AJNR. American journal of neuroradiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01502917 (A Phase I Study of Convection-Enhanced Delivery of 124I-Omburtamab for Patients With Non-Progressive Diffuse Pontine Gliomas Previously Treated With External Beam Radiation Therapy), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01502917 phase1completednot on this map

A Phase I Study of Convection-Enhanced Delivery of 124I-Omburtamab for Patients With Non-Progressive Diffuse Pontine Gliomas Previously Treated With External Beam Radiation Therapy

TypeinterventionalSponsorY-mAbs TherapeuticsRan2011 to 2022Enrolled50ConditionsBrain Cancer, Brain Stem GliomaArmsRadioactive iodine-labeled monoclonal antibody omburtamab, External Beam Radiotherapy
3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

D I GuisadoFrom the Weill Medical College of Cornell University (D.I.G., R.S.), New York, NY.ORCID 0000-0001-9980-4794
R SinghFrom the Weill Medical College of Cornell University (D.I.G., R.S.), New York, NY.ORCID 0000-0002-3651-5415
S MinkowitzDepartments of Radiology (S.M., A.J.T.).ORCID 0000-0001-6279-8853
Z ZhouNeurological Surgery (Z.Z., M.M.S.), Weill Medical College of Cornell University, New York, New York.ORCID 0000-0001-5774-3823
S HaqueDepartments of Radiology (S.H., K.K.P., R.J.Y., S.B.T.).ORCID 0000-0003-4673-9997
K K PeckDepartments of Radiology (S.H., K.K.P., R.J.Y., S.B.T.) Medical Physics (K.K.P., S.B.T.), Memorial Sloan Kettering Cancer Center, New York, New York.ORCID 0000-0002-9841-3078
R J YoungDepartments of Radiology (S.H., K.K.P., R.J.Y., S.B.T.).ORCID 0000-0001-7003-3017
A J TsiourisDepartments of Radiology (S.M., A.J.T.).ORCID 0000-0002-9281-716X
M M SouweidaneNeurological Surgery (Z.Z., M.M.S.), Weill Medical College of Cornell University, New York, New York Neurosurgery (M.M.S.).ORCID 0000-0001-5627-4551
S B ThakurDepartments of Radiology (S.H., K.K.P., R.J.Y., S.B.T.) Medical Physics (K.K.P., S.B.T.), Memorial Sloan Kettering Cancer Center, New York, New York. thakurs@mskcc.org.ORCID 0000-0001-8090-3696

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Elisa de Stanchina · 1985 to 2026
$347.4M
Summer research experiences for medical students supervised by faculty mentorsR25CA020449 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Charlotte Eielson Ariyan · 1985 to 2026
$6.2M
NCI NIH HHS P30 CA008748NCI NIH HHS R25 CA020449
6 · The paper itself

Abstract

background and purposeDiffuse intrinsic pontine gliomas are inoperable high-grade gliomas with a median survival of less than 1 year. Convection-enhanced delivery is a promising local drug-delivery technique that can bypass the BBB in diffuse intrinsic pontine glioma treatment. Evaluating tumor response is critical in the assessment of convection-enhanced delivery of treatment. We proposed to determine the potential of 3D multivoxel (1)H-MR spectroscopy to evaluate convection-enhanced delivery treatment effect in these tumors. MATERIALS AND

methodsWe prospectively analyzed 3D multivoxel (1)H-MR spectroscopy data for 6 patients with nonprogressive diffuse intrinsic pontine gliomas who received convection-enhanced delivery treatment of a therapeutic antibody (Phase I clinical trial NCT01502917). To compare changes in the metabolite ratios with time, we tracked the metabolite ratios Cho/Cr and Cho/NAA at several ROIs: normal white matter, tumor within the convection-enhanced delivery infusion site, tumor outside of the infused area, and the tumor average.

resultsThere was a comparative decrease in both Cho/Cr and Cho/NAA metabolite ratios at the tumor convection-enhanced delivery site versus tumor outside the infused area. We used MR spectroscopy voxels with dominant white matter as a reference. The difference between changes in metabolite ratios became more prominent with increasing time after convection-enhanced delivery treatment.

conclusionsThe comparative change in metabolite ratios between the convection-enhanced delivery site and the tumor site outside the infused area suggests that multivoxel (1)H-MR spectroscopy, in combination with other imaging modalities, may provide a clinical tool to accurately evaluate local tumor response after convection-enhanced delivery treatment.

Indexed as

Antineoplastic AgentsBrain Stem NeoplasmsConvectionDrug Delivery SystemsFemaleGliomaHumansMagnetic Resonance SpectroscopyMaleMiddle AgedAntineoplastic Agents

Identifiers

PMID26939629
PMCPMC4947015

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.